Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung
Clinical trial NCT04496674 · TERMINATED
Trial details
- NCT number
- NCT04496674
- Sponsor
- German Cancer Research Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2023-05-03
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.